The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University ...
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...
BioNTech SE has reached a settlement agreement with the University of Pennsylvania over a royalty dispute related to its COVID-19 vaccine, developed in collaboration with Pfizer. The agreement ...
Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National ...
The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...
The latest update is out from BioNTech SE ( (BNTX ... Newsletter BioNTech SE has reached a settlement agreement with the University of Pennsylvania over a royalty dispute related to its COVID ...
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University of Pennsylvania concerning royalties and other related amounts ...